Heterologous prime-boost vaccination targeting MAGE-type antigens promotes tumor T-cell infiltration and improves checkpoint blockade therapy

por McAuliffe, James, Chan, Hok Fung, Noblecourt, Laurine, Ramirez-Valdez, Ramiro Andrei, Pereira-Almeida, Vinnycius, Zhou, Yaxuan, Pollock, Emily, Cappuccini, Federica, Redchenko, Irina, Hill, Adrian VS, Leung, Carol Sze Ki, Van den Eynde, Benoit J
Publicado 2021

Intravenous heterologous prime-boost vaccination activates innate and adaptive immunity to promote tumor regression

por Ramirez-Valdez, Ramiro A., Baharom, Faezzah, Khalilnezhad, Ahad, Fussell, Sloane C., Hermans, Dalton J., Schrager, Alexander M., Tobin, Kennedy K.S., Lynn, Geoffrey M., Khalilnezhad, Shabnam, Ginhoux, Florent, Van den Eynde, Benoit J., Leung, Carol Sze Ki, Ishizuka, Andrew S., Seder, Robert A.
Publicado 2023